Bronchiolitis Obliterans (BO) Recruiting Phase 3 Trials for Cyclosporine (DB00091)

Also known as: Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome (BOS) / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0116742 (Bronchiolitis Obliterans (BO))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03657342A Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A Inhalation Solution in the Treatment of CLAD/Bronchiolitis Obliterans Syndrome in Patients Post Single Lung TransplantTreatment
NCT03656926A Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A Inhalation Solution in the Treatment of CLAD/Bronchiolitis Obliterans Syndrome in Patients Post Double Lung TransplantTreatment